Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988524770> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W1988524770 endingPage "787" @default.
- W1988524770 startingPage "782" @default.
- W1988524770 abstract "In southern Africa, brown oculocutaneous albinism (BOCA) is a distinct pigmentation phenotype. In at least two cases, it has occurred in the same families as tyrosinase-positive oculocutaneous albinism (OCA2), suggesting that it may be allelic, despite the fact that this phenotype was attributed to mutations in the TYRP1 gene in an American individual of mixed ancestry. Linkage analysis in five families mapped the BOCA locus to the same region as the OCA2 locus (maximum LOD 3.07; θ=0 using a six-marker haplotype). Mutation analysis of the human homologue of the mouse pink-eyed dilution gene (P), in 10 unrelated individuals with BOCA revealed that 9 had one copy of the 2.7-kb deletion. No other mutations were identified. Additional haplotype studies, based on closely linked markers (telomere to centromere: D15S1048, D15S1019, D15S1533, P-gene 2.7-kb deletion, D15S219, and D15S156) revealed several BOCA-associated P haplotypes. These could be divided into two core haplotypes, suggesting that a limited number of P-gene mutations give rise to this phenotype. In southern Africa, brown oculocutaneous albinism (BOCA) is a distinct pigmentation phenotype. In at least two cases, it has occurred in the same families as tyrosinase-positive oculocutaneous albinism (OCA2), suggesting that it may be allelic, despite the fact that this phenotype was attributed to mutations in the TYRP1 gene in an American individual of mixed ancestry. Linkage analysis in five families mapped the BOCA locus to the same region as the OCA2 locus (maximum LOD 3.07; θ=0 using a six-marker haplotype). Mutation analysis of the human homologue of the mouse pink-eyed dilution gene (P), in 10 unrelated individuals with BOCA revealed that 9 had one copy of the 2.7-kb deletion. No other mutations were identified. Additional haplotype studies, based on closely linked markers (telomere to centromere: D15S1048, D15S1019, D15S1533, P-gene 2.7-kb deletion, D15S219, and D15S156) revealed several BOCA-associated P haplotypes. These could be divided into two core haplotypes, suggesting that a limited number of P-gene mutations give rise to this phenotype. Brown oculocutaneous albinism (BOCA; MIM 203290) or type IV oculocutaneous albinism (fig. 1) was first described in black individuals in Malawi (Stannus Stannus, 1913Stannus HS Anomalies of pigmentation among natives of Nyasaland: a contribution to the study of albinism.Biometrica. 1913; 9: 333-365Google Scholar) and later was named “brown albinism” by King et al. (King et al., 1980King RA Creel D Cervenka J Okoro AN Witkop CJ Albinism in Nigeria with delineation of a new recessive oculocutaneous type.Clin Genet. 1980; 17: 259-270Crossref PubMed Scopus (42) Google Scholar), after their study in Nigeria. Affected individuals were noted to have cream to light tan skin, beige to light brown hair, and blue-green to brown irides with moderate transillumination defects, nystagmus, and reduced retinal pigment. They were found to be distinct from the rufous type of albinism (Kromberg et al. Kromberg et al., 1990Kromberg JGR Castle DJ Zwane EM Bothwell J Kidson S Bartel P Philips JI Jenkins T Red or rufous albinism in Southern Africa.Ophthalmic Paediatr Genet. 1990; 2: 229-235Crossref Scopus (34) Google Scholar). Ultrastructurally, their melanocytes are normal, but their melanosomes appear not to reach maturity, with only small amounts of melanin deposition (King and Rich King and Rich, 1986King RA Rich SS Segregation analysis of brown oculocutaneous albinism.Clin Genet. 1986; 29: 496-501Crossref PubMed Scopus (5) Google Scholar). Because of their lighter skin, affected individuals, particularly in Africa, are at greater risk of developing malignant skin lesions than are their normally pigmented counterparts (Kromberg Kromberg, 1985Kromberg JGR (1985) A genetic and psychosocial study of Albinism in southern Africa. Ph.D. thesis, University of the Witwatersrand, JohannesburgGoogle Scholar). The phenotype has not been described in white individuals, although King and Rich (King and Rich, 1986King RA Rich SS Segregation analysis of brown oculocutaneous albinism.Clin Genet. 1986; 29: 496-501Crossref PubMed Scopus (5) Google Scholar) have suggested that, in this population, it may be analogous to autosomal recessive ocular albinism. BOCA is inherited as an autosomal recessive disorder. Two observations suggested the possible involvement of the human homologue of the mouse pink-eyed dilution gene (P) in the BOCA phenotype. The first was the occurrence of BOCA and OCA2 (caused by mutations in the P gene) in different members of the same family. Two families were found to fit this category. The second observation was that the BOCA phenotype is similar to that of OCA2, but represents a much milder form. The P gene and other candidate pigment loci were tested for linkage to BOCA. In this study, linkage analysis was performed in five families comprising 16 affected and 19 unaffected individuals. Diagnosis of the condition was based on a number of characteristic features: a light-brown skin that tans on exposure to sunlight; an accumulation of pigment, to a small degree, with age; brown hair; blue or brown irides; and presence of the visual anomalies associated with albinism: nystagmus, photophobia, reduced visual acuity, and sometimes strabismus (King et al. King et al., 1980King RA Creel D Cervenka J Okoro AN Witkop CJ Albinism in Nigeria with delineation of a new recessive oculocutaneous type.Clin Genet. 1980; 17: 259-270Crossref PubMed Scopus (42) Google Scholar). The following candidate loci were identified, and polymorphic markers at or close to each locus were tested for linkage to the disorder in the 35 subjects: the P gene, which, when mutated, usually results in OCA2 (Rinchik et al. Rinchik et al., 1993Rinchik EM Bultman SJ Horsthemke B Lee ST Strunk KM Spritz RA Avidano KM Jong MTC Nicholls RD A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism.Nature. 1993; 361: 72-76Crossref PubMed Scopus (312) Google Scholar); tyrosinase (TYR), a critical enzyme in the melanin biosynthesis pathway that displays activity in BOCA above the mean value for brown-haired white individuals (King and Rich King and Rich, 1986King RA Rich SS Segregation analysis of brown oculocutaneous albinism.Clin Genet. 1986; 29: 496-501Crossref PubMed Scopus (5) Google Scholar); tyrosinase-related protein 1 (TYRP1), which has been implicated in an OCA phenotype classified as BOCA by Boissy et al. (Boissy et al., 1996Boissy RE Zhao H Oetting WS Austin LM Wildenberg SC Boissy YL Zhao Y Sturm RA Hearing VJ King RA Nordlund JJ Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as “OCA3”.Am J Hum Genet. 1996; 58: 1145-1156PubMed Google Scholar), but which the present authors have shown to be rufous oculocutaneous albinism (ROCA) in southern African populations (Manga et al. Manga et al., 1997Manga P Kromberg JGR Box NF Jenkins T Ramsay R Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene.Am J Hum Genet. 1997; 61: 1095-1101Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar); and tyrosinase-related protein 2 (TYRP2), which codes for another enzyme in the melanin pathway (Sturm et al. Sturm et al., 1994Sturm RA Baker E Sutherland GR Assignment of the tyrosinase-related protein-2 gene (TYRP2) to human chromosome 13q31-q32 by fluorescence in situ hybridisation: extended synteny with mouse chromosome 14.Genomics. 1994; 21: 293-296Crossref PubMed Scopus (10) Google Scholar). Polymorphic markers at the selected loci were characterized in each family, and two-point linkage analysis was carried out. TYR, TYRP1, and TYRP2 were excluded from linkage to BOCA (table 1). Linkage to the P locus could not be excluded but remained equivocal with individual P gene–associated markers.Table 1Two-Point LOD-Score Analysis between Candidate Pigment Loci and BOCAθCandidate LocusaThe markers used for TYR, TYRP1, and TYRP2 were intragenic and recombinations were observed, excluding each locus.Chromosomal Position0.10.20.30.40.50Reference for MarkersTYR11q14-q21−∞−.54−.06.04.02.00Morris et al. (Morris et al., 1991Morris SW Muir W St Clair D Dinucleotide repeat polymorphism at the human tyrosinase gene.Nucleic Acids Res. 1991; 19: 6968Crossref PubMed Scopus (15) Google Scholar)TYRP19p23−∞−.78−.31−.11−.02.00Box and Sturm (Box and Sturm, 1994Box NF Sturm RA Dinucleotide repeat polymorphism at the human TYRP1 locus.Hum Mol Genet. 1994; 3: 2270Crossref PubMed Scopus (6) Google Scholar)TYRP213q13-q32−∞−.63−.27−.11−.03.00Sturm et al. (Sturm et al., 1994Sturm RA Baker E Sutherland GR Assignment of the tyrosinase-related protein-2 gene (TYRP2) to human chromosome 13q31-q32 by fluorescence in situ hybridisation: extended synteny with mouse chromosome 14.Genomics. 1994; 21: 293-296Crossref PubMed Scopus (10) Google Scholar)P haplotypebThe markers screened for in the P haplotype (D15S10, D15S11, GABRB3, D15S97, GABRA5, IR10, and CMW, of which IR10 [Nicholls et al. 1989] and CMW [Rich et al. 1988] were screened by Southern blot analysis and the remainder by PCR and polyacrylamide gel electrophoresis) all showed Zmax values at θ=0, except D15S11 (θ=.10); and the Zmax values for the markers were 0.77, 1.19, 2.41, 2.47, 0.40, and 0.84, respectively. When combined into a P haplotype, they gave an overall Zmax of 3.07 at θ=0.15q11-123.072.261.46.73.20.00a The markers used for TYR, TYRP1, and TYRP2 were intragenic and recombinations were observed, excluding each locus.b The markers screened for in the P haplotype (D15S10, D15S11, GABRB3, D15S97, GABRA5, IR10, and CMW, of which IR10 [Nicholls et al. Nicholls et al., 1989Nicholls RD Knoll JH Glatt K Hersh JH Brewster TD Garham JM Wurster-Hill D Wharton R Latt SA Restriction fragment length polymorphisms within proximal 15q and their use in molecular cytogenetics and the Prader-Willi syndrome.Am J Med Genet. 1989; 33: 66-77Crossref PubMed Scopus (96) Google Scholar] and CMW [Rich et al. Rich et al., 1988Rich DC Witowsky CM Summers KM van Tuinen P Ledbetter DH Highly polymorphic locus D15S24 (CMW-1) maps to 15pter-q13.Nucleic Acids Res. 1988; 16: 8740Crossref PubMed Scopus (21) Google Scholar] were screened by Southern blot analysis and the remainder by PCR and polyacrylamide gel electrophoresis) all showed Zmax values at θ=0, except D15S11 (θ=.10); and the Zmax values for the markers were 0.77, 1.19, 2.41, 2.47, 0.40, and 0.84, respectively. When combined into a P haplotype, they gave an overall Zmax of 3.07 at θ=0. Open table in a new tab P gene–associated haplotypes based on the markers D15S10-D15S11-D15S97-GABRB3-GABRA5-IR10-CMW were therefore constructed for each family and were used as a single “marker” to test for linkage. The markers were ordered according to a consensus map based on data from Kuwano et al. (Kuwano et al., 1992Kuwano A Mutirangura A Dittrich B Buiting K Horsthemke B Saitoh S Niikawa N Ledbetter SA Greenberg F Chinault AC Ledbetter DH Molecular dissection of the Prader-Willi/Angelman syndrome region (15q11-q13) by YAC cloning and FISH analysis.Hum Mol Genet. 1992; 1: 417-425Crossref PubMed Scopus (132) Google Scholar), Mutirangura et al. (Mutirangura et al., 1993Mutirangura A Jayakumar A Sutcliffe JS Nakao M Mckinney MJ Buiting K Horsthemke B Beaudet AL Chinault AC Ledbetter D A complete YAC contig of the Prader-Willi/Angelman chromosome region (15q11-q13) and refined localization of the SNRPN gene.Genomics. 1993; 18: 546-552Crossref PubMed Scopus (80) Google Scholar), and Kedda et al. (Kedda et al., 1994Kedda M-A Stevens G Van Beukering J Jenkins T Ramsay M The tyrosinase-positive oculocutaneous albinism gene shows locus homogeneity on chromosome 15q11-q13 and evidence of multiple mutations in southern African negroids.Am J Hum Genet. 1994; 54 (erratum: Am J Hum Genet 55:602 [1994]): 1078-1084PubMed Google Scholar). A maximum LOD of 3.07 (θ=0) was obtained for two-point linkage analysis, suggesting the involvement of the P gene in the etiology of BOCA. Once linkage had been established to markers mapping to chromosome 15q11-q13 and the P gene had been identified as the most likely candidate, mutation analysis was carried out for the P gene in affected individuals. A further five unrelated subjects with BOCA were included in the mutation screen. The strategy was to look first for structural alterations, using Southern blotting. Secondly, an exon-by-exon screen using SSCP and sequence analysis was carried out for each of the 25 exons (Lee et al. Lee et al., 1995Lee ST Nicholls RD Jong MTC Fukai K Spritz RA Organization and sequence of the human P gene and identification of a new family of transport proteins.Genomics. 1995; 26: 354-363Crossref PubMed Scopus (147) Google Scholar). The 2.7-kb deletion, which removes exon 7 of the P gene (Durham-Pierre et al. Durham-Pierre et al., 1994Durham-Pierre D Gardner JM Nakatsu Y King RA Francke U Ching A Aquaron R Marmol V Brilliant MH African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism.Nat Genet. 1994; 7: 176-179Crossref PubMed Scopus (86) Google Scholar) and is known to account for the majority (77%) of OCA2 cases in southern Africa (Stevens et al. Stevens et al., 1997Stevens G Ramsay M Jenkins T Oculocutaneous albinism (OCA2) in sub-Saharan Africa: distribution of the common 2.7-kb deletion mutation.Hum Genet. 1997; 99: 523-527Crossref PubMed Scopus (43) Google Scholar), was also screened for in affected individuals. The 2.7-kb deletion was found in the heterozygous state in 9 of 10 unrelated individuals with BOCA, giving it a frequency of .45 in this group. The mutation has a high carrier rate, 1 in 78, in the normally pigmented population (Stevens et al. Stevens et al., 1997Stevens G Ramsay M Jenkins T Oculocutaneous albinism (OCA2) in sub-Saharan Africa: distribution of the common 2.7-kb deletion mutation.Hum Genet. 1997; 99: 523-527Crossref PubMed Scopus (43) Google Scholar). Thus, the frequency is significantly higher in BOCA subjects (χ2=38.2; P=6.39×10−10), confirming that P is involved in the BOCA phenotype. No definitive pathogenic mutations, other than the 2.7-kb deletion, were identified in the nine subjects tested, although many polymorphic variants were observed (Kerr et al. Kerr et al., 2000Kerr R Stevens G Manga P Salm S John P Haw T Ramsay M Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.Hum Mutat. 2000; 15: 166-172Crossref PubMed Scopus (35) Google Scholar). Additional haplotype analysis was performed with closely linked microsatellite markers to determine whether there was a single or multiple origins for BOCA P alleles. The following markers were used (telomere→centromere): D15S1048, D15S1019, D15S1533, P-gene 2.7-kb deletion, D15S219, and D15S156. The distance between the outer markers is ∼1.03 Mb, according to the Draft Genome Browser. The order of all these markers and their primer sequences, excluding D15S1533, were obtained from the Genome Database. D15S1533 represents a new polymorphic microsatellite marker that was detected on a partially sequenced BAC (RP11-322N14, AC017046). This BAC contains some of the P-gene exons. An algorithm designed by A. Christoffels was used to detect AC repeats of >10 units. This BAC contains 14 unordered segments, of which segment 11 contained an AC repeat of interest. The primers for D15S1533 are: (F) 5′-CTTGGCAACATCCCTGTATCA-3′ and (R) 5′-TGAATGCCATTATTTCATTCCTT-3′. The exact position of D15S1533 in relation to the 2.7-kb deletion of P is not known. Haplotype analysis using the closely linked markers is shown together with the BOCA pedigrees in figure 2 and is detailed in [table 2]. Five different (nondeletion) haplotypes probably derived from two ancestral haplotypes were observed to be segregating with the brown allele, suggesting that there is a small number of mutations (possibly one common mutation) associated with this phenotype. In three of the six families (families 2, 4, and 6), the OCA2 2.7-kb–deletion core haplotype appeared with the same BOCA haplotype. This common BOCA haplotype was not seen in 18 chromosomes of control individuals from the same population, suggesting that it is not common in the general population (data not shown).Table 2P-Gene–Associated Haplotypes in BOCA SubjectsFamilyD15S1048D15S1019D15S15332.7-kb DeletionaN=no deletion; D=2.7-kb P-gene deletion.D15S219D15S1562(ZBBB)211N524(ZBBE)211N526(ZBZA)211N521(ZBBA)421N525(ZBBG)211N311(ZBBA)417N453(ZBBD)397N214(ZBBE)634D345(ZBBG)394D346(ZBZA)154D342(ZBBB)444D343(ZBBD)174D51Note.—Boxed areas indicate conserved regions of the haplotype. With respect to the OCA2 individuals within these families, the OCA2 individual in family 5 shares the same deletion haplotype with the BOCA individual in family 2, whereas the OCA2 individuals in family 6, in addition to the deletion haplotype obtained from their BOCA parent, have a different deletion haplotype (5-7-4-D-3-4) that shows the core haplotype (boxed region) but, again, no conservation telomeric to the core haplotype. Microsatellite analyses were performed by amplification of products with fluorescently labeled primers and electrophoresis on a 4.2% polyacrylamide gel using an ABI Prism 377 DNA sequencer. GeneScan software was used to size the amplimers. An allele-numbering system for the various product sizes, at each locus, was used to simplify the data. The numbering was used consistently throughout the study (details not shown).a N=no deletion; D=2.7-kb P-gene deletion. Open table in a new tab Note.— Boxed areas indicate conserved regions of the haplotype. With respect to the OCA2 individuals within these families, the OCA2 individual in family 5 shares the same deletion haplotype with the BOCA individual in family 2, whereas the OCA2 individuals in family 6, in addition to the deletion haplotype obtained from their BOCA parent, have a different deletion haplotype (5-7-4-D-3-4) that shows the core haplotype (boxed region) but, again, no conservation telomeric to the core haplotype. Microsatellite analyses were performed by amplification of products with fluorescently labeled primers and electrophoresis on a 4.2% polyacrylamide gel using an ABI Prism 377 DNA sequencer. GeneScan software was used to size the amplimers. An allele-numbering system for the various product sizes, at each locus, was used to simplify the data. The numbering was used consistently throughout the study (details not shown). Linkage analysis was not performed on these markers, because there were no observed recombination events within families, which confirms tight linkage between these markers and the P gene. Two ancestral hot spots for recombination are suggested, as depicted in [table 2] (between D15S1019 and D15S1533 and between the 2.7-kb deletion of P and D15S219). The region most often conserved in BOCA patients is between D15S1533 and D15S156 indicating that the pathogenic mutations giving rise to this phenotype are within this region. The BOCA-associated haplotypes are conserved over a larger region (D15S1048–D15S156) than are the 2.7-kb deletion haplotypes (conserved from D15S1533 to D15S156), indicating that at least one BOCA mutation is likely to be evolutionarily more recent than the 2.7-kb deletion. On the basis of the data presented here, there is good support for the hypothesis that BOCA in southern African individuals is caused by mutations in the P gene, despite the fact that no additional pathogenic mutations were identified. This is contrary to findings in one BOCA subject presented by Boissy et al. (Boissy et al., 1996Boissy RE Zhao H Oetting WS Austin LM Wildenberg SC Boissy YL Zhao Y Sturm RA Hearing VJ King RA Nordlund JJ Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as “OCA3”.Am J Hum Genet. 1996; 58: 1145-1156PubMed Google Scholar), in whom mutations were found in the TYRP1 gene. The phenotype in that case may have been modified by the genetic background and mixed ancestry of the individual. BOCA is a mild phenotype, and, in the affected southern African individuals, the second mutation may well be a milder mutation, possibly in the promoter region (down-regulating expression) or in other unscreened regions of the P gene. We propose that BOCA mutations are rare, and that the phenotype is only expressed when present together with another mutation at the OCA2 locus. Individuals who do not carry a severe OCA2 mutation but are homozygous for the milder BOCA mutations may be expected to be phenotypically normal, but perhaps tend towards the lighter part of the spectrum of normal skin-color variation. We sincerely thank the family members who participated in this study. The assistance of Sr. E. Zwane, Matron V. Masisi, Dr. T. de Ravel, and Ms. M. Seotsa is greatly appreciated. We are grateful to the Lesotho Department of Health for its cooperation during this study. The AC repeat giving rise to the new polymorphic microsatellite marker was identified by Alan Christoffels, using a personally designed algorithm. Financial support from the South African Medical Research Council, the University of the Witwatersrand, the South African Institute for Medical Research, and the Foundation for Research and Development is gratefully acknowledged." @default.
- W1988524770 created "2016-06-24" @default.
- W1988524770 creator A5012766647 @default.
- W1988524770 creator A5031621413 @default.
- W1988524770 creator A5055162088 @default.
- W1988524770 creator A5056545989 @default.
- W1988524770 creator A5063352293 @default.
- W1988524770 date "2001-03-01" @default.
- W1988524770 modified "2023-10-18" @default.
- W1988524770 title "In Southern Africa, Brown Oculocutaneous Albinism (BOCA) Maps to the OCA2 Locus on Chromosome 15q: P-Gene Mutations Identified" @default.
- W1988524770 cites W110122724 @default.
- W1988524770 cites W1681773190 @default.
- W1988524770 cites W1974268067 @default.
- W1988524770 cites W1981203869 @default.
- W1988524770 cites W1996267187 @default.
- W1988524770 cites W2001780311 @default.
- W1988524770 cites W2003490009 @default.
- W1988524770 cites W2005014380 @default.
- W1988524770 cites W2030226370 @default.
- W1988524770 cites W2049991715 @default.
- W1988524770 cites W2057626992 @default.
- W1988524770 cites W2062956770 @default.
- W1988524770 cites W2078772015 @default.
- W1988524770 cites W2086473822 @default.
- W1988524770 cites W2090770002 @default.
- W1988524770 cites W2094609226 @default.
- W1988524770 cites W2108707281 @default.
- W1988524770 cites W2149277955 @default.
- W1988524770 doi "https://doi.org/10.1086/318800" @default.
- W1988524770 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1274491" @default.
- W1988524770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11179026" @default.
- W1988524770 hasPublicationYear "2001" @default.
- W1988524770 type Work @default.
- W1988524770 sameAs 1988524770 @default.
- W1988524770 citedByCount "34" @default.
- W1988524770 countsByYear W19885247702012 @default.
- W1988524770 countsByYear W19885247702013 @default.
- W1988524770 countsByYear W19885247702014 @default.
- W1988524770 countsByYear W19885247702016 @default.
- W1988524770 countsByYear W19885247702018 @default.
- W1988524770 countsByYear W19885247702019 @default.
- W1988524770 countsByYear W19885247702020 @default.
- W1988524770 countsByYear W19885247702021 @default.
- W1988524770 countsByYear W19885247702022 @default.
- W1988524770 crossrefType "journal-article" @default.
- W1988524770 hasAuthorship W1988524770A5012766647 @default.
- W1988524770 hasAuthorship W1988524770A5031621413 @default.
- W1988524770 hasAuthorship W1988524770A5055162088 @default.
- W1988524770 hasAuthorship W1988524770A5056545989 @default.
- W1988524770 hasAuthorship W1988524770A5063352293 @default.
- W1988524770 hasBestOaLocation W19885247701 @default.
- W1988524770 hasConcept C104317684 @default.
- W1988524770 hasConcept C127716648 @default.
- W1988524770 hasConcept C2775849878 @default.
- W1988524770 hasConcept C2775902910 @default.
- W1988524770 hasConcept C30481170 @default.
- W1988524770 hasConcept C54355233 @default.
- W1988524770 hasConcept C63971535 @default.
- W1988524770 hasConcept C64618202 @default.
- W1988524770 hasConcept C84597430 @default.
- W1988524770 hasConcept C86803240 @default.
- W1988524770 hasConceptScore W1988524770C104317684 @default.
- W1988524770 hasConceptScore W1988524770C127716648 @default.
- W1988524770 hasConceptScore W1988524770C2775849878 @default.
- W1988524770 hasConceptScore W1988524770C2775902910 @default.
- W1988524770 hasConceptScore W1988524770C30481170 @default.
- W1988524770 hasConceptScore W1988524770C54355233 @default.
- W1988524770 hasConceptScore W1988524770C63971535 @default.
- W1988524770 hasConceptScore W1988524770C64618202 @default.
- W1988524770 hasConceptScore W1988524770C84597430 @default.
- W1988524770 hasConceptScore W1988524770C86803240 @default.
- W1988524770 hasIssue "3" @default.
- W1988524770 hasLocation W19885247701 @default.
- W1988524770 hasLocation W19885247702 @default.
- W1988524770 hasLocation W19885247703 @default.
- W1988524770 hasLocation W19885247704 @default.
- W1988524770 hasOpenAccess W1988524770 @default.
- W1988524770 hasPrimaryLocation W19885247701 @default.
- W1988524770 hasRelatedWork W1504303356 @default.
- W1988524770 hasRelatedWork W1681773190 @default.
- W1988524770 hasRelatedWork W1988524770 @default.
- W1988524770 hasRelatedWork W2023415645 @default.
- W1988524770 hasRelatedWork W2030226370 @default.
- W1988524770 hasRelatedWork W2038664369 @default.
- W1988524770 hasRelatedWork W2090770002 @default.
- W1988524770 hasRelatedWork W2628665853 @default.
- W1988524770 hasRelatedWork W2738843963 @default.
- W1988524770 hasRelatedWork W4238236449 @default.
- W1988524770 hasVolume "68" @default.
- W1988524770 isParatext "false" @default.
- W1988524770 isRetracted "false" @default.
- W1988524770 magId "1988524770" @default.
- W1988524770 workType "article" @default.